Neumora Therapeutics Inc
NMRA1.655USD
+0.095+6.09%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
267.69MMarket Cap
LossP/E TTM
Neumora Therapeutics Inc
1.655
+0.095+6.09%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-38.40%-59.45M
2.14%-50.34M
29.91%-33.48M
-81.03%-56.16M
-30.01%-42.95M
---51.44M
---47.77M
-16.71%-31.02M
-2.66%-33.04M
-95.92%-26.58M
-111.14%-32.19M
-77.76%-29.35M
---17.26M
---13.57M
---15.24M
---16.51M
Net income from continuing operations
-26.57%-67.99M
45.90%-58.82M
-36.81%-72.55M
-52.30%-58.70M
-50.80%-53.72M
---108.73M
---53.03M
-26.90%-38.54M
17.23%-35.63M
-78.54%-30.37M
-181.25%-43.04M
-34.86%-26.97M
---178.03M
---17.01M
---15.30M
---20.00M
Operating gains losses
-0.63%157.00K
-5.42%157.00K
-9.83%156.00K
-6.43%160.00K
0.00%158.00K
--166.00K
--173.00K
11.04%171.00K
7.48%158.00K
23.20%154.00K
11.36%147.00K
-68.28%131.00K
--150.00K
--125.00K
--132.00K
--413.00K
Other non-cash items
-15.73%-412.00K
-100.35%-225.00K
-166.67%-472.00K
-366.55%-1.35M
-356.41%-356.00K
--64.18M
---177.00K
-199.66%-290.00K
-100.59%-78.00K
7.38%291.00K
8163.75%13.22M
-82.72%803.00K
--156.86M
--271.00K
--160.00K
--4.65M
Change in working capital
-114.62%-525.00K
89.66%-1.36M
2567.23%29.43M
-277.22%-9.03M
1062.14%3.59M
---13.11M
---1.19M
194.62%5.10M
107.62%309.00K
-20.97%1.73M
-338.96%-4.06M
-97.44%-4.48M
--2.25M
--2.19M
---924.00K
---2.27M
-Change in prepaid expenses
-86.86%966.00K
107.37%599.00K
356.79%17.69M
-129.56%-9.74M
-6.45%7.35M
---8.13M
---6.89M
-3219.12%-4.24M
1121.85%7.86M
-24.02%136.00K
-251.08%-769.00K
-2451.69%-2.27M
---677.00K
--179.00K
--509.00K
---89.00K
-Change in other current assets
----
----
----
----
----
--0.00
--0.00
--0.00
-100.00%0.00
100.00%0.00
51046.67%7.67M
-10758.82%-3.62M
--5.00K
---59.00K
--15.00K
--34.00K
Cash from non-recurring investing activities
Cash from operating activities
-38.40%-59.45M
2.14%-50.34M
29.91%-33.48M
-81.03%-56.16M
-30.01%-42.95M
---51.44M
---47.77M
-16.71%-31.02M
-2.66%-33.04M
-95.92%-26.58M
-111.14%-32.19M
-77.76%-29.35M
---17.26M
---13.57M
---15.24M
---16.51M
Investing cash flow
Net cash from continuing investing activities
100.00%0.00
4956.99%234.34M
-424391.89%-156.99M
-192.00%-40.79M
19.18%-35.80M
--4.63M
--37.00K
24260.44%44.34M
-436.22%-44.30M
66.97%182.00K
48900.00%13.18M
-39.35%188.00K
--547.00K
--109.00K
---27.00K
--310.00K
Capital expenditures
-100.00%0.00
4956.99%234.34M
-100.00%0.00
-100.00%0.00
2052.78%775.00K
--4.63M
--37.00K
24260.44%44.34M
-99.73%36.00K
30.94%182.00K
4726.37%13.18M
-85.54%188.00K
--547.00K
--139.00K
--273.00K
--1.30M
Net cash flow from disposal of fixed assets
----
4956.99%234.34M
-424391.89%-156.99M
-192.00%-40.79M
17.43%-36.58M
--4.63M
--37.00K
24260.44%44.34M
-436.22%-44.30M
66.97%182.00K
48900.00%13.18M
-39.35%188.00K
--547.00K
--109.00K
---27.00K
--310.00K
Net cash flow from intangible asset transactions
-100.00%0.00
--0.00
--0.00
--0.00
--775.00K
----
----
----
----
----
----
----
----
----
----
----
Net cash flow from investment products
123.77%44.16M
640.22%135.54M
----
-128.56%-19.54M
-347.90%-185.80M
--18.31M
--23.85M
175.27%68.41M
42.73%-41.48M
---90.89M
---72.43M
--0.00
--0.00
--0.00
--0.00
--0.00
Net cash flow from other investing activities
----
--8.10M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
129.44%44.16M
-822.37%-98.80M
559.20%156.99M
-11.72%21.25M
-5424.85%-150.00M
--13.68M
--23.82M
126.44%24.08M
103.29%2.82M
-83450.46%-91.07M
-317159.26%-85.61M
39.35%-188.00K
---547.00K
---109.00K
--27.00K
---310.00K
Financing cash flow
Cash flow from continuous financing activities
-100.00%0.00
3337.63%15.57M
-99.34%1.53M
808.90%2.65M
1726.73%1.84M
---481.00K
--232.02M
-85.98%292.00K
128.77%101.00K
225.47%2.08M
-128.31%-351.00K
-103.03%-358.00K
--291.99M
--640.00K
--1.24M
--11.80M
Net cash flow from common stock issuance/repurchase
----
--13.69M
----
--0.00
100.00%0.00
--0.00
--233.38M
--0.00
---491.00K
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
--960.00K
--0.00
Net cash flow from preferred stock issuance/repurchase
----
----
----
----
----
----
----
----
----
----
----
-100.53%-63.00K
--291.24M
----
----
--11.80M
Proceeds from stock option exercised by employees
-100.00%0.00
387.91%1.65M
16.21%1.76M
556.93%2.65M
206.48%1.84M
--339.00K
--1.51M
-82.50%404.00K
267.07%602.00K
260.63%2.31M
-41.43%164.00K
--846.00K
--743.00K
--640.00K
--280.00K
--0.00
Net cash flow from other financing activities
----
127.44%225.00K
92.14%-225.00K
100.00%0.00
100.00%0.00
---820.00K
---2.86M
50.22%-112.00K
98.06%-10.00K
---225.00K
---515.00K
---1.14M
----
--0.00
--0.00
----
Net cash from non-recurrent financing activities
Net cash from financing activities
-100.00%0.00
3337.63%15.57M
-99.34%1.53M
808.90%2.65M
1726.73%1.84M
---481.00K
--232.02M
-85.98%292.00K
128.77%101.00K
225.47%2.08M
-128.31%-351.00K
-103.03%-358.00K
--291.99M
--640.00K
--1.24M
--11.80M
Net cash flow
Beginning cash balance
-61.80%143.36M
-33.03%276.93M
-26.06%151.89M
-13.18%184.14M
54.93%375.25M
--413.50M
--205.43M
-27.18%212.08M
-40.83%242.21M
63.50%291.23M
113.10%409.37M
122.84%439.27M
--165.09M
--178.13M
--192.10M
--197.12M
Current period cash flow changes
92.00%-15.29M
-249.23%-133.57M
-39.91%125.04M
-384.80%-32.25M
-534.44%-191.11M
---38.25M
--208.07M
94.24%-6.65M
74.50%-30.12M
-786.52%-115.57M
-745.27%-118.14M
-495.46%-29.90M
--274.18M
---13.04M
---13.98M
---5.02M
Ending cash balance
-30.45%128.07M
-61.80%143.36M
-33.03%276.93M
-26.06%151.89M
-13.18%184.14M
--375.25M
--413.50M
16.95%205.43M
-27.18%212.08M
6.40%175.66M
63.50%291.23M
113.10%409.37M
--439.27M
--165.09M
--178.13M
--192.10M
Free cash flow
-35.94%-59.45M
-407.67%-284.68M
29.97%-33.48M
25.48%-56.16M
-32.21%-43.73M
---56.08M
---47.81M
-181.59%-75.36M
27.08%-33.08M
-95.26%-26.76M
-192.34%-45.36M
-65.84%-29.54M
---17.80M
---13.71M
---15.52M
---17.81M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
